174 related articles for article (PubMed ID: 31083176)
1. GRIK4 and GRM7 gene may be potential indicator of venlafaxine treatment reponses in Chinese of Han ethnicity.
Sun Q; Yuan F; Yuan R; Ren D; Zhu Y; Bi Y; Hu J; Guo Z; Xu F; Niu W; Ma G; Wu X; Yang F; Wang L; Li X; Yu T; He L; He G
Medicine (Baltimore); 2019 May; 98(19):e15456. PubMed ID: 31083176
[TBL] [Abstract][Full Text] [Related]
2. Common variants in GRIK4 and major depressive disorder: An association study in the Chinese Han population.
Ren D; Bi Y; Xu F; Niu W; Zhang R; Hu J; Guo Z; Wu X; Cao Y; Huang X; Yang F; Wang L; Li W; Xu Y; He L; Yu T; He G; Li X
Neurosci Lett; 2017 Jul; 653():239-243. PubMed ID: 28583584
[TBL] [Abstract][Full Text] [Related]
3. CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population.
Zhu Y; Zhang N; Ren D; Bi Y; Xu F; Niu W; Sun Q; Guo Z; Yuan R; Yuan F; Wu X; Cao Y; Yang F; Wang L; Du L; Li W; Xu Y; Li X; Zhu L; He L; Shi L; He G; Yu T
Clin Neuropharmacol; 2019; 42(2):32-36. PubMed ID: 30875344
[TBL] [Abstract][Full Text] [Related]
4. No association between CYP2C19 genetic polymorphism with treatment remission to antidepressant venlafaxine in Han Chinese population.
Zhang N; Ji L; Chen Z; An L; Ren D; Bi Y; Guo Z; Yuan R; Yuan F; Dong Z; Yin L; Sun X; Yang F; Li X; Yu T; He L; Shi L; He G
Psychiatr Genet; 2020 Feb; 30(1):30-33. PubMed ID: 31842058
[TBL] [Abstract][Full Text] [Related]
5. A novel NR3C2 polymorphism and the increased thyroid-stimulating hormone concentration are associated with venlafaxine treatment outcome in Chinese Han MDD patients.
Yuan F; Yuan R; Ren D; Bi Y; Niu W; Guo Z; Wu X; Xu F; Sun Q; Ma G; Yang F; Zhu Y; Yu T; Li X; He L; Shi L; He G
Psychiatry Res; 2020 Feb; 284():112690. PubMed ID: 31757642
[TBL] [Abstract][Full Text] [Related]
6. Significant association of GRM7 and GRM8 genes with schizophrenia and major depressive disorder in the Han Chinese population.
Li W; Ju K; Li Z; He K; Chen J; Wang Q; Yang B; An L; Feng G; Sun W; Zhou J; Zhang S; Song P; Khan RAW; Ji W; Shi Y
Eur Neuropsychopharmacol; 2016 Jan; 26(1):136-146. PubMed ID: 26655190
[TBL] [Abstract][Full Text] [Related]
7.
Sun Q; Yuan F; Ren D; Ma G; Yang F; Wu X; He L; He G
Neuropsychiatr Dis Treat; 2019; 15():657-661. PubMed ID: 30880991
[TBL] [Abstract][Full Text] [Related]
8. SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.
Yeh YW; Chen CJ; Jang FL; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Shyu JF; Wan FJ; Lu RB; Huang SY
J Psychiatr Res; 2015 Feb; 61():33-9. PubMed ID: 25512257
[TBL] [Abstract][Full Text] [Related]
9. No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients.
Wu N; Liu L; Ren D; Yuan F; Bi Y; Guo Z; Hou B; Ji L; Han K; Feng M; Su K; Yu T; Li X; Yang F; Sun X; Dong Z; Yu S; Yi Z; Xu Y; He L; Wu S; Zhao L; Changqun C; Shi Y; He G
Clin Neuropharmacol; 2021 Mar-Apr 01; 44(2):53-56. PubMed ID: 33480616
[TBL] [Abstract][Full Text] [Related]
10. Association study of GRM7 polymorphisms with major depressive disorder in the Chinese Han population.
Niu W; Huang X; Yu T; Chen S; Li X; Wu X; Cao Y; Zhang R; Bi Y; Yang F; Wang L; Li W; Xu Y; He L; He G
Psychiatr Genet; 2017 Apr; 27(2):78-79. PubMed ID: 28027116
[No Abstract] [Full Text] [Related]
11. Association study of GRM7 polymorphisms and schizophrenia in the Chinese Han population.
Niu W; Huang X; Yu T; Chen S; Li X; Wu X; Cao Y; Zhang R; Bi Y; Yang F; Wang L; Li W; Xu Y; He L; He G
Neurosci Lett; 2015 Sep; 604():109-12. PubMed ID: 26254163
[TBL] [Abstract][Full Text] [Related]
12. The role of GRIK4 gene in treatment-resistant depression.
Milanesi E; Bonvicini C; Congiu C; Bortolomasi M; Gainelli G; Gennarelli M; Minelli A
Genet Res (Camb); 2015 Jul; 97():e14. PubMed ID: 26139080
[TBL] [Abstract][Full Text] [Related]
13. Impact of GRIK4 gene polymorphisms on cognitive dysfunction in patients with major depression.
Pu M; Wang X; Zhang J
Rev Neurol (Paris); 2020 Dec; 176(10):823-828. PubMed ID: 32245654
[TBL] [Abstract][Full Text] [Related]
14. Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder.
Chiesa A; Lia L; Lia C; Lee SJ; Han C; Patkar AA; Pae CU; Serretti A
J Int Med Res; 2013 Jun; 41(3):809-15. PubMed ID: 23613500
[TBL] [Abstract][Full Text] [Related]
15. No genetic association between polymorphisms in the kainate-type glutamate receptor gene, GRIK4, and schizophrenia in the Chinese population.
Li Z; He Z; Tang W; Tang R; Huang K; Xu Z; Xu Y; Li L; Li X; Feng G; He L; Shi Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):876-80. PubMed ID: 18289755
[TBL] [Abstract][Full Text] [Related]
16. Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study.
Li Z; Qi D; Chen J; Zhang C; Yi Z; Yuan C; Wang Z; Hong W; Yu S; Cui D; Fang Y
Psychoneuroendocrinology; 2013 Jan; 38(1):107-14. PubMed ID: 22683211
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.
Ng C; Sarris J; Singh A; Bousman C; Byron K; Peh LH; Smith DJ; Tan CH; Schweitzer I
Hum Psychopharmacol; 2013 Sep; 28(5):516-22. PubMed ID: 24014145
[TBL] [Abstract][Full Text] [Related]
18. Glutamate receptor metabotropic 7 (GRM7) gene polymorphisms in mood disorders and attention deficit hyperactive disorder.
Noroozi R; Taheri M; Omrani MD; Ghafouri-Fard S
Neurochem Int; 2019 Oct; 129():104483. PubMed ID: 31170425
[TBL] [Abstract][Full Text] [Related]
19. The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.
Taranu A; Asmar KE; Colle R; Ferreri F; Polosan M; David D; Becquemont L; Corruble E; Verstuyft C
Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):435-441. PubMed ID: 28627776
[TBL] [Abstract][Full Text] [Related]
20. Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR*D.
Fabbri C; Drago A; Serretti A
Eur Neuropsychopharmacol; 2013 Jul; 23(7):612-21. PubMed ID: 22884879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
